Cue Biopharma GAAP EPS of -$4.74 misses by $2.50, revenue of $0.01M misses by $1.02M
at seekingalpha.com (Mon, 16-Nov 4:52 PM)
Cue Biopharma spotlights durable CSU response as CUE-221 holds benefit 12 weeks after last dose
Market Chameleon (Mon, 21-Sep 11:02 AM)
Market Chameleon (Mon, 21-Sep 7:05 AM)